Gala 1-3 Gal Series
 
 

Man, apes and Old World monkeys differ from other mammals in the expression of a-galactosyl epitopes (Galili et al (1988) J. Biol. Chem. 263: 17755). All human sera contain a large amount of naturally occurring antibody (anti-Gal) which binds to oligosaccharides terminating in the disaccharide Gala1-3Gal (Galili et al (1985) J. Exp. Med. 162: 573). These antigens (termed Galili antigens) are established as major xenoantigens on pig endothelium and are thus responsible for initiating the hyperacute rejection of pig organs by Old World primates and humans. In the future development of xenotransplantation, these compounds are of primary significance.

It is thought that the full structure to which human anti-pig antibodies bind is the pentasacchardie Gala1-3Galb1-4GlcNAcb1-3Galb1-4Glc.

We have manufactured a series of oligosaccharides terminating in Gala1-3Gal including the pentasacchardie and linear B-6 (Lee at al (1998) Transplantation 66(8): in print) to facilitate the study of hyperacute rejection. We also make an extensive series of glycoconjugates in which oliosaccharides are linked to protiens and lipids.


 
 G203
 
     a1-3 Galactobiose
 
Gala1-3Gal
C12H22O11 - FW 342.30 5mg 25mg
 
 G334
 
     a1-3,b1-4 Galactotriose
 
Gala1-3Galb1-4Gal
C18H32O16 - FW 504.44 5mg 25mg
 
 GN334
 
     Linear B-2 trisaccharide
 
Gala1-3Galb1-4GlcNAc
Commonly found sequence in non-primate mammals
C20H35NO16 - FW 545.50 2mg 5mg 10mg
 
 L330
 
     Linear B-6 trisaccharide
 
Gala1-3Galb1-4Glc
An analogue of GN334. B6 is a powerful ligand for Anti-gal antibodies Lee et al. (1998) Transplantation 66(8)
C18H22O16 - FW504.44 2mg 5mg 10mg
 
 G443
 
     a1-3,b1-4, a1-3 Galactotetraose
 
Gala1-3Galb1-4Gala1-3Gal
C24H42O21-FW666.60 5mg 25mg
 
 G205
 
     a1-3 Galactobiosyl b-Methyl glycoside
 
Gala1-3Galb1-O-Me
C13H24O11 - FW 356.32 5mg 25mg